Work

Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment

Year: 2010

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2010.07.021

Authors: Cécile Ortholan, Jérôme Durivault, Jean-Michel Hannoun-Levi, Mélanie Guyot, Christine Bourcier, Damien Ambrosetti, Stephen Safe, Gilles Pagès

Institutions: Centre National de la Recherche Scientifique, Université Nice Sophia Antipolis, Centre Antoine Lacassagne, Hôpital Pasteur, Texas A&M Health Science Center, Texas A&M University

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2143556151

FWCI: 2.48

Cites: 67

Cited by: 33

Related to: 10